ABSTRACT
Purpose: This study aimed to reveal the association between the osteoporosis self-assessment tool for Asians (OSTA) and airflow limitation (AL) in post-menopausal Japanese women. Participants and Methods: This cross-sectional study included 1580 participants undergoing a comprehensive health examination using spirometry and dual-energy X-ray absorptiometry. The OSTA was calculated by subtracting the age in years from the body weight (BW) in kilograms, and the result was multiplied by 0.2. The OSTA risk level was defined as low (>-1), moderate (-4 to -1), or high (<-4). AL was defined as forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC) <0.7. The association between the OSTA and AL was assessed using logistic regression analysis. Results: The prevalence of AL was significantly higher in the high OSTA group (15.3%) than in the low OSTA group (3.1%) (p<0.001). In multiple linear regression analysis, the OSTA was independently associated with FEV1/FVC. In logistic regression models adjusted for smoking status, alcohol consumption, current use of medication for diabetes, hyperglycemia, rheumatoid arthritis, second-hand smoke, and ovary removal showed a significantly higher risk of AL (odds ratio: 5.48; 95% confidence interval: 2.90-10.37; p<0.001) in participants with OSTA high risk than in those with OSTA low risk. Conclusion: These results suggest that the OSTA high risk indicates reduced BMD at the femoral neck and presence of AL in Japanese post-menopausal women aged ≥45 years.
Subject(s)
Absorptiometry, Photon , Asian People , Lung , Postmenopause , Spirometry , Humans , Female , Cross-Sectional Studies , Middle Aged , Japan/epidemiology , Aged , Forced Expiratory Volume , Risk Factors , Vital Capacity , Prevalence , Lung/physiopathology , Osteoporosis, Postmenopausal/physiopathology , Osteoporosis, Postmenopausal/ethnology , Osteoporosis, Postmenopausal/diagnosis , Osteoporosis, Postmenopausal/epidemiology , Predictive Value of Tests , Logistic Models , Risk Assessment , Bone Density , Linear Models , Pulmonary Disease, Chronic Obstructive/physiopathology , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/ethnology , Pulmonary Disease, Chronic Obstructive/epidemiology , Diagnostic Self Evaluation , Odds Ratio , East Asian PeopleABSTRACT
Bone Strain Index (BSI) is a new dual-energy x-ray absorptiometry (DXA)-based index. We retrospectively evaluated data from 153 postmenopausal women with a history of type 2 diabetes mellitus (T2DM). Lumbar spine and femoral Bone Strain Index (BSI) were sensitive to skeletal impairment in postmenopausal women suffering from T2DM. PURPOSE: Bone Strain Index (BSI) is a new dual-energy X-ray absorptiometry (DXA)-based measurement. We evaluated the performance of BSI in predicting the presence of fragility fractures in type 2 diabetes mellitus (T2DM) postmenopausal women. METHODS: We retrospectively evaluated data from a case-control study of 153 postmenopausal women with a history of at least 5 years of T2DM (age from 40 to 90 years). For each subject, we assessed the personal or familiar history of previous fragility fractures and menopause age, and we collected data about bone mineral density (BMD), BSI, and Trabecular Bone Score (TBS) measurements. Statistical analysis was performed having as outcome the history of fragility fractures. RESULTS: Out of a total of 153 subjects, n = 22 (14.4%) presented at least one major fragility fracture. A negative correlation was found between lumbar BSI and lumbar BMD (r = - 0.49, p < 0.001) and between total femur BSI and total femur BMD (r = - 0.49, p < 0.001). A negative correlation was found between femoral neck BSI and femoral neck BMD (r = - 0.22, p < 0.001). Most DXA-based variables were individually able to discriminate between fractured and non-fractured subjects (p < 0.05), and lumbar BSI was the index with the most relative difference between the two populations, followed by femoral BSI. CONCLUSION: Lumbar spine and femoral BSI are sensitive to skeletal impairment in postmenopausal women suffering from T2DM. The use of BSI in conjunction with BMD and TBS can improve fracture risk assessment.
Subject(s)
Absorptiometry, Photon , Bone Density , Diabetes Mellitus, Type 2 , Lumbar Vertebrae , Postmenopause , Humans , Female , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/physiopathology , Middle Aged , Aged , Retrospective Studies , Lumbar Vertebrae/diagnostic imaging , Lumbar Vertebrae/physiopathology , Aged, 80 and over , Postmenopause/physiology , Case-Control Studies , Adult , Osteoporotic Fractures/physiopathology , Osteoporotic Fractures/diagnostic imaging , Femur/diagnostic imaging , Femur/physiopathology , Osteoporosis, Postmenopausal/diagnostic imaging , Osteoporosis, Postmenopausal/physiopathologyABSTRACT
AIM: To study the association of bone mineral density (BMD) with serum biochemical and immunological markers in postmenopausal women with rheumatoid arthritis (RA). MATERIALS AND METHODS: The study included 173 women with RA (age 61.0 [56.0; 66.0] years). A survey, dual-energy X-ray absorptiometry to measure the BMD of the lumbar spine (LI-LIV), femoral neck (FN) and total hip (TH), routine blood chemistry, measurement of C-reactive protein (CRP), rheumatoid factor, cyclic citrullinated peptide antibodies (CCPA), parathyroid hormone (PTH), vitamin D3, myostatin, follistatin, interleukin-6 (IL-6), IL-6 receptors, insulin-like growth factor 1, adiponectin, leptin, fibroblast growth factor 23, and tumor necrosis factor SF12 were performed. RESULTS: PTH (ß=-0.22, -0.35 and -0.30 for LI-LIV, FN and TH, respectively), CRP (ß=-0.18, 0.23 and -0.22 for LI-LIV, FN and TH, respectively) and leptin (ß=0.35, 0.32 and 0.42 for LI-LIV, FN and TH, respectively) were shown a significant association with BMD in all sites of measurement. It was independent of age, body mass index and postmenopause duration. Associations were also found between adiponectin and BMD of LI-LIV and TH (ß=-0.36 and -0.28, respectively), CCPA and BMD of FN and TH (ß=-0.21, -0.24, respectively) and IL-6 and BMD of FN (ß=0.37). CONCLUSION: The study of biochemical and immunological markers in women with RA demonstrated that CRP, CCPA, PTH, IL-6, adiponectin, and leptin influenced BMD.
Subject(s)
Arthritis, Rheumatoid , Biomarkers , Bone Density , Humans , Female , Arthritis, Rheumatoid/blood , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/physiopathology , Bone Density/physiology , Middle Aged , Biomarkers/blood , Absorptiometry, Photon/methods , Aged , Postmenopause/blood , Postmenopause/immunology , C-Reactive Protein/analysis , C-Reactive Protein/metabolism , Adiponectin/blood , Osteoporosis, Postmenopausal/blood , Osteoporosis, Postmenopausal/immunology , Osteoporosis, Postmenopausal/physiopathology , Osteoporosis, Postmenopausal/etiology , Leptin/bloodABSTRACT
Numerical models of bone remodelling have traditionally been used to perform in silico tests of bone loss in postmenopausal women and also to simulate the response to different drug treatments. These models simulate the menopausal oestrogen decline by altering certain signalling pathways. However, they do not consider the simultaneous effect that ageing can have on cell function and bone remodelling, and thus on bone loss. Considering ageing and oestrogen decline together is important for designing osteoporosis treatments that can selectively counteract one or the other disease mechanism. A previously developed bone cell population model was adapted to consider the effect of ageing through: (1) the decrease of TGF- ß contained in the bone matrix and (2) an increased production of sclerostin by non-skeletal cells. Oestrogen deficiency is simulated in three different ways: (a) an increase in RANKL expression, (b) a decrease in OPG production, and (c) an increase in the responsiveness of osteoclasts to RANKL. The effect of ageing was validated using the cross-sectional study of (Riggs et al. in J Bone Miner Res 19: 1945-1954, 2004) on BMD of trabecular bone of the vertebral body of men. The joint effect of ageing and oestrogen deficiency was validated using these same clinical results but in women. In ageing, the effect of the increasing production of sclerostin is more important than the decrease of TGF- ß , while the three mechanisms used to simulate the effect of oestrogen deficiency produce almost identical responses. The results show that an early menopause leads to a lower average density in the fifth decade, but after the sixth decade the average density is independent of the age at menopause. Treatment of osteoporosis with denosumab was also simulated to conclude that the drug is not very effective if started before 10 years after menopause or before age 60.
Subject(s)
Aging , Computer Simulation , Osteoporosis , Humans , Female , Male , Postmenopause/physiology , Models, Biological , Signal Transduction , Middle Aged , RANK Ligand/metabolism , Aged , Estrogens/metabolism , Osteoporosis, Postmenopausal/physiopathology , Transforming Growth Factor beta/metabolismABSTRACT
OBJECTIVE: To explore the multi-component synergistic mechanism of Zuogui Wan (, ZGW) in treating postmenopausal osteoporosis (PMOP). METHODS: The main components and target genes of ZGW were screened via the Traditional Chinese Medicine Systems Pharmacology (TCMSP). In addition, the target gene sets of PMOP were derived from the GeneCards and Online Mendelian Inheritance in Man databases. The search tool for recurring instances of neighbouring genes (STRING) 11.0 software was used to analyze the interaction among intersecting genes. Cytoscape 3.6.1 software and the Matthews correlation coefficient (MCC) algorithm were used to screen the core genes. Fifty Sprague-Dawley female rats were randomly divided into the sham-operated (Sham) group and the four ovariectomized (OVX) subgroups. Rats subjected to Sham or OVX were administered with the vehicle (OVX, 1 mL water/100 g weight), 17ß-estradiol (E2, 50 µg·kg-1·d-1), and lyophilized powder of ZGW at a low dose of 2.3 (ZGW-L) and high dose of 4.6 (ZGW-H) g·kg-1·d-1 for three months. The bone density and bone strength were assessed using dual-energy X-ray and three-point bending tests, respectively. Furthermore, enzyme-linked immun-osorbent assay, Hematoxylin-eosin staining, and western blot analysis were used to determine the potential pharmacological mechanisms of action of ZGW in PMOP. RESULTS: A total of 117 active compounds of ZGW were screened from the TCMSP. Furthermore, 108 intersecting genes of drugs and diseases were identified. Using STRING software and the MCC algorithm, ten core genes, including C-X-C chemokine living 8 (CXCL8), C-C chemokine receptor type 2 (CCR2), alpha-2a active receptor (ADRA2A), melatonin receptor type 1B (MTNR1B), and amyloid-beta A4 protein (APP), were identified. The anti-osteoporosis regulation network of ZGW was constructed using the Cytoscape software. The animal experiments demonstrated that ZGW groups significantly reduced the serum levels of ß-C-terminal telopeptide of type I collagen (ß-CTX) and increased serum levels of bone-specific alkaline phosphatase (BALP) (P < 0.05, P < 0.01). The OVX group exhibited a significant decrease in bone mineral density and bone strength compared with the Sham group (P < 0.01). Moreover, treatment with ZGW resulted in increased trabecular thickness, improved arrangement of trabecular structure, and reduced empty bone lacunae. Furthermore, treatment with ZGW significantly increased the protein expression of CXCL8, ADRA2A, and CCR2 (P < 0.05, P < 0.01), and significantly decreased the protein expression of Runx2 (P < 0.01). Furthermore, the ZGW and E2 groups demonstrated significantly increased BMD (P < 0.05, P < 0.01), improved bone strength (P < 0.05, P < 0.01), reduced expression of CXCL8, ADRA2A, and CCR2, and increased runt-related transcription factor 2 levels in bone tissue (P < 0.05, P < 0.01) compared with the OVX group. However, there were no significant differences in MTNR1B and APP expression among the groups. CONCLUSION: ZGW shows synergistic mechanisms in PMOP through multiple components, targets, and pathways.
Subject(s)
Bone Density , Drugs, Chinese Herbal , Osteoporosis, Postmenopausal , Rats, Sprague-Dawley , Drugs, Chinese Herbal/administration & dosage , Female , Animals , Osteoporosis, Postmenopausal/drug therapy , Osteoporosis, Postmenopausal/genetics , Osteoporosis, Postmenopausal/physiopathology , Osteoporosis, Postmenopausal/metabolism , Rats , Humans , Bone Density/drug effectsSubject(s)
Bone Density , Osteoporotic Fractures , Humans , Bone Density/physiology , Female , Osteoporotic Fractures/prevention & control , Osteoporotic Fractures/physiopathology , Osteoporotic Fractures/etiology , Osteoporosis, Postmenopausal/physiopathology , Osteoporosis, Postmenopausal/complications , Forearm/physiologySubject(s)
Bone Density , Osteoporotic Fractures , Humans , Bone Density/physiology , Female , Osteoporotic Fractures/physiopathology , Osteoporotic Fractures/epidemiology , Osteoporotic Fractures/etiology , Osteoporosis, Postmenopausal/physiopathology , Osteoporosis, Postmenopausal/complications , Forearm/physiology , Absorptiometry, Photon/methodsABSTRACT
Post hoc analysis of FRAME and ARCH revealed that on-study nonvertebral and vertebral fractures by Month 12 were less common in women initially treated with romosozumab versus placebo or alendronate. Recurrent fracture risk was also lower in romosozumabtreated patients, and there were no fracturerelated complications. Results support continuing romosozumab treatment postfracture. PURPOSE: Post hoc analysis evaluating efficacy and safety of romosozumab, administered in the immediate postfracture period, in the FRAME and ARCH phase 3 trials. METHODS: In FRAME (NCT01575834) and ARCH (NCT01631214), postmenopausal women with osteoporosis were randomized 1:1 to romosozumab 210 mg monthly or comparator (FRAME, placebo; ARCH, alendronate 70 mg weekly) for 12 months, followed by antiresorptive therapy (FRAME, denosumab; ARCH, alendronate). In patients who experienced on-study nonvertebral or new/worsening vertebral fracture by Month 12, we report the following: fracture and treatmentemergent adverse event (TEAE) incidence through 36 months, bone mineral density changes (BMD), and romosozumab timing. Due to the sample sizes employed, meaningful statistical comparisons between treatments were not possible. RESULTS: Incidence of on-study nonvertebral and vertebral fractures by Month 12 was numerically lower in romosozumab- versus comparator-treated patients (FRAME, 1.6% and 0.5% versus 2.1% and 1.6%; ARCH, 3.4% and 3.3% versus 4.6% and 4.9%, respectively). In those who experienced on-study nonvertebral fracture by Month 12, recurrent nonvertebral and subsequent vertebral fracture incidences were numerically lower in patients initially treated with romosozumab versus comparator (FRAME, 3.6% [2/56] and 1.8% [1/56] versus 9.2% [7/76] and 3.9% [3/76]; ARCH, 10.0% [7/70] and 5.7% [4/70] versus 12.6% [12/95] and 8.4% [8/95], respectively). Among those with on-study vertebral fracture by Month 12, recurrent vertebral and subsequent nonvertebral fracture incidences were numerically lower with romosozumab versus comparator (FRAME, 0.0% [0/17] and 0.0% [0/17] versus 11.9% [7/59] and 8.5% [5/59]; ARCH, 9.0% [6/67] and 7.5% [5/67] versus 15.0% [15/100] and 16.0% [16/100], respectively). In patients with fracture by Month 12, no fracturerelated complications were reported in romosozumab-treated patients. BMD gains were numerically greater with romosozumab than comparators. CONCLUSION: Data suggest support for the efficacy and safety of continuing romosozumab treatment following fracture. TRIAL REGISTRATIONS: NCT01575834; NCT01631214.
Subject(s)
Alendronate , Antibodies, Monoclonal , Bone Density Conservation Agents , Denosumab , Osteoporosis, Postmenopausal , Osteoporotic Fractures , Spinal Fractures , Humans , Female , Osteoporotic Fractures/prevention & control , Bone Density Conservation Agents/therapeutic use , Bone Density Conservation Agents/adverse effects , Bone Density Conservation Agents/administration & dosage , Spinal Fractures/prevention & control , Spinal Fractures/physiopathology , Aged , Osteoporosis, Postmenopausal/drug therapy , Osteoporosis, Postmenopausal/physiopathology , Osteoporosis, Postmenopausal/complications , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal/adverse effects , Antibodies, Monoclonal/administration & dosage , Middle Aged , Alendronate/therapeutic use , Alendronate/administration & dosage , Alendronate/adverse effects , Denosumab/therapeutic use , Denosumab/adverse effects , Denosumab/administration & dosage , Double-Blind Method , Bone Density/drug effects , Aged, 80 and over , Drug Administration Schedule , RecurrenceABSTRACT
BACKGROUND/AIMS: Vasomotor symptoms (VMS) adversely affect postmenopausal quality of life. However, their association with bone health has not been elucidated. This study aimed to systematically review and meta-analyze the evidence regarding the association of VMS with fracture risk and bone mineral density (BMD) in peri- and postmenopausal women. METHODS: A literature search was conducted in PubMed, Scopus and Cochrane databases until 31 August 2023. Fracture, low BMD (osteoporosis/osteopenia) and mean change in lumbar spine (LS) and femoral neck (FN) BMD were assessed. The results are presented as odds ratio (OR) and mean difference (MD), respectively, with a 95% confidence interval (95% CI). The I2 index quantified heterogeneity. RESULTS: Twenty studies were included in the qualitative and 12 in the quantitative analysis (n=49,659). No difference in fractures between women with and without VMS was found (n=5, OR 1.04, 95% CI 0.93-1.16, I2 16%). However, VMS were associated with low BMD (n=5, OR 1.54, 95% CI 1.42-1.67, I2 0%). This difference was evident for LS (MD -0.019 g/cm2, 95% CI -0.03 to -0.008, I2 85.2%), but not for FN BMD (MD -0.010 g/cm2, 95% CI -0.021 to 0.001, I2 78.2%). These results were independent of VMS severity, age and study design. When the analysis was confined to studies that excluded menopausal hormone therapy use, the association with BMD remained significant. CONCLUSIONS: The presence of VMS is associated with low BMD in postmenopausal women, although it does not seem to increase fracture risk.
Subject(s)
Bone Density , Femur Neck , Lumbar Vertebrae , Observational Studies as Topic , Osteoporosis, Postmenopausal , Osteoporotic Fractures , Postmenopause , Humans , Bone Density/physiology , Female , Osteoporotic Fractures/physiopathology , Osteoporotic Fractures/etiology , Osteoporotic Fractures/epidemiology , Osteoporosis, Postmenopausal/physiopathology , Osteoporosis, Postmenopausal/complications , Femur Neck/physiopathology , Lumbar Vertebrae/physiopathology , Postmenopause/physiology , Hot Flashes/physiopathology , Hot Flashes/complications , Vasomotor System/physiopathology , Risk Assessment/methods , Risk FactorsABSTRACT
Long-term physical functioning trajectories following distal forearm fracture are unknown. We found that women with versus those without distal forearm fracture were more likely to experience a 5-year decline in physical functioning, independent of initial physical functioning level. This association was most evident among women 80 years and older. INTRODUCTION: Physical functioning trajectory following lower arm or wrist fracture is not well understood. PURPOSE: This study is to evaluate physical functioning trajectory before vs. after lower arm or wrist fracture, stratified by age. METHODS: We performed a nested case-control study of prospective data from the Women's Health Initiative Study (n = 2097 cases with lower arm or wrist fracture, 20,970 controls). Self-reported fractures and the physical functioning subscale of the RAND 36-item Short-Form Health Survey were assessed annually. We examined three physical functioning trajectory groups: stable, improving, and declining. RESULTS: Mean (SD) number of physical functioning measurements was 5.2 (1.5) for cases and 5.0 (1.4) for controls. Declining physical functioning was observed among 20.4% of cases and 16.0% of controls. Compared to women without lower arm or wrist fracture, women with lower arm or wrist fracture were 33% more likely to experience declining physical functioning (adjusted odds ratio [aOR] 1.33 95% confidence interval [CI] 1.19-1.49, reference group stable or improving physical functioning trajectory). Associations varied by age: age ≥ 80 years aOR 1.56 (95% CI 1.29-1.88); age 70-79 years aOR 1.29 (95% CI 1.09-1.52); age < 70 years aOR 1.15 (95% CI 0.86-1.53) (pinteraction = 0.06). Associations between lower arm or wrist fracture and odds of declining physical functioning did not vary by baseline physical functioning or physical activity level. CONCLUSIONS: Women with lower arm or wrist fracture, particularly those aged 80 and older, were more likely to experience declines in physical functioning than women without such fractures, independent of baseline physical functioning level.
Subject(s)
Osteoporotic Fractures , Wrist Injuries , Humans , Female , Aged , Wrist Injuries/physiopathology , Wrist Injuries/epidemiology , Aged, 80 and over , Case-Control Studies , Osteoporotic Fractures/physiopathology , Osteoporotic Fractures/epidemiology , Osteoporotic Fractures/rehabilitation , Middle Aged , Prospective Studies , Postmenopause/physiology , Age Factors , Radius Fractures/physiopathology , Radius Fractures/epidemiology , United States/epidemiology , Osteoporosis, Postmenopausal/physiopathology , Osteoporosis, Postmenopausal/complicationsABSTRACT
Bone mineral density measured at the ultra-distal forearm site was associated with any fracture, as well as distal radius fracture in women from a longitudinal cohort study. PURPOSE: Femoral neck (BMDhip) and lumbar spine (BMDspine) bone mineral density (BMD) are routinely used to assess fracture risk. More data are needed to understand how ultra-distal forearm BMD (BMDUDforearm) may assist fracture prediction. METHODS: Using a Lunar DPX-L, Geelong Osteoporosis Study women (n = 1026), aged 40-90 years, had BMD measured. Incident low-trauma fractures were radiologically verified. Using Cox proportional hazard models, hazard ratios (HR) were calculated for BMDUDforearm as a continuous variable (expressed as a one-unit decrease in T-score) and a categorical variable (normal/osteopenia/osteoporosis). Areas under receiver operating characteristics (AUROC) curves were calculated. Analyses were conducted for any fracture and distal radius fractures. RESULTS: During 14,270 person-years of follow-up, there were 318 fractures (85 distal radius). In adjusted models, continuous BMDUDforearm was associated with any (HR 1.26;95%CI 1.15-1.39) and distal radius fractures (HR 1.59;95%CI 1.38-1.83). AUROCs for continuous BMDUDforearm, 33% forearm(BMD33%forearm), BMDhip, BMDspine, and FRAX without BMD were similar for any fracture (p > 0.05). For distal radius fracture, the AUROC for BMDUDforearm was higher than other sites and FRAX (p < 0.05). In adjusted models, those with osteoporosis had a higher likelihood of any fracture (HR 2.12; 95%CI 1.50-2.98). For distal radius fractures, both osteopenia and osteoporosis had a higher risk (HR 4.31; 95%CI 2.59-7.15 and 4.81; 95%CI 2.70-8.58). AUROCs for any fracture were similar for categorical BMD at all sites but lower for FRAX (p < 0.05). For distal radius fractures, the AUROC for BMDUDforearm, was higher than other sites and FRAX (p < 0.05). CONCLUSION: Ultra-distal forearm BMD may aid risk assessments for any distal radius fractures.
Subject(s)
Absorptiometry, Photon , Bone Density , Forearm , Osteoporosis, Postmenopausal , Osteoporotic Fractures , Radius Fractures , Humans , Female , Bone Density/physiology , Aged , Osteoporotic Fractures/physiopathology , Osteoporotic Fractures/epidemiology , Osteoporotic Fractures/etiology , Middle Aged , Radius Fractures/epidemiology , Radius Fractures/physiopathology , Radius Fractures/etiology , Adult , Aged, 80 and over , Forearm/physiopathology , Forearm/physiology , Absorptiometry, Photon/methods , Osteoporosis, Postmenopausal/physiopathology , Osteoporosis, Postmenopausal/complications , Osteoporosis, Postmenopausal/epidemiology , Risk Assessment/methods , Incidence , Femur Neck/physiopathology , Longitudinal StudiesABSTRACT
OBJECTIVE: to evaluate the effect of body composition, nutritional habits (NH), and physical activity (PA) levels on bone mineral density (BMD) in osteoporotic postmenopausal women (OPW). Subjects and method: the demographic characteristics, anthropometric measurements, PA status, information on NH, some biochemical findings, and BMD measurements of 100 OPWs were evaluated. RESULTS: in this study, 48 % of the women were classified as obese. The obese women were found to have lower vitamin D levels and higher parathyroid hormone levels than those of the over-weight women. A positive correlation was found between body mass index and L1L4, L2L4, and femur BMD (r = 0.268, p < 0.001; r = 0.241, p < 0.01; r = 0.369, p < 0.001, respectively). There was a significant decrease in L1L4 and femur BMD with increasing age (r = -0.224, p < 0.05; r = -0.366, p < 0.001, respectively). Femur BMD showed a positive correlation with duration (hours/week) and frequency of PA (days/week). According to the logistic regression analysis, body weight, daily tea consumption, and PA were positively associated with femur BMD, while advanced age, the age of menarche, salt and coffee consumption, and postmenopausal fracture status were negatively associated. CONCLUSION: we observed that body weight, some nutritional factors, and active lifestyle have seemed to effect BMD in OPWs. An adequate, balanced nutrition maintaining the ideal weight, and regular physical activity may improve bone health in OPWs
OBJETIVO: evaluar el efecto de la composición corporal, los hábitos nutricionales (NH) y los niveles de actividad física (PA) sobre la densidad mineral ósea (BMD) en mujeres posmenopáusicas osteoporóticas (OPW). Sujetos y método: se evaluaron las características demográficas, mediciones antropométricas, estado de PA, información sobre NH, algunos hallazgos bioquímicos y datos de BMD de 100 OPW. RESULTADOS: en este estudio, el 48 % de las mujeres se clasificaron como obesas. Se encontró que las mujeres obesas tenían niveles más bajos de vitamina D y niveles más altos de hormona paratiroidea que los de las pacientes con sobrepeso. Se encontró una correlación positiva entre el índice de masa corporal y L1L4, L2L4 y la BMD del fémur (r = 0,268, p < 0,001; r = 0,241, p < 0,01; r = 0,369, p < 0,001, respectivamente). Hubo una disminución significativa de los valores de L1L4 y BMD femoral con el aumento de la edad (r = -0,224, p < 0,05; r = -0,366, p < 0,001, respectivamente). La BMD del fémur mostró una correlación positiva con la duración (horas/semana) y la frecuencia (días/semana) de la PA. Según el análisis de regresión logística, el peso corporal, el consumo diario de té y la PA se asociaron positivamente con la BMD del fémur, mientras que la edad avanzada, la edad de la menarquia, el consumo de sal y café, y la presencia o no de fracturas posmenopáusicas se asociaron negativamente. CONCLUSIÓN: observamos que el peso corporal, algunos factores nutricionales y el estilo de vida activo parecen haber afectado la BMD en las OPW. Una nutrición adecuada y equilibrada, el mantenimiento del peso ideal y la actividad física regular pueden mejorar la salud ósea de las OPW
Subject(s)
Humans , Female , Middle Aged , Adult , Aged , Osteoporosis, Postmenopausal/complications , Bone Density , Body Composition , Motor Activity/physiology , Feeding Behavior , Osteoporosis, Postmenopausal/physiopathology , Anthropometry , Obesity/complications , Obesity/diagnosis , Vitamin D Deficiency/diet therapy , Overweight , Body Mass Index , Logistic Models , Body Weight/physiologyABSTRACT
ABSTRACT Objective: To verify which component of body composition (BC) has greater influence on postmenopausal women bone mineral density (BMD). Subjects and methods: Four hundred and thirty women undergoing treatment for osteoporosis and 513 untreated women, except for calcium and vitamin D. Multiple linear regression analysis was performed in order to correlated BMD at lumbar spine (LS), total femur (FT), femoral neck (FN) with body mass (BM), total lean mass (LM) and total fat mass (FM), all determined by DXA. Results: BM significantly correlated with all bone sites in untreated and treated women (r = 0.420 vs 0.277 at LS; r = 0.490 vs 0.418 at FN, r = 0.496 vs 0.414 at FT, respectively). In untreated women, the LM correlated better than FM with all sites, explaining 179% of LS; 32.3% of FN and 30.2% of FT; whereas FM explained 13.2% of LS; 277% of FN, 23.4% of FT In treated women, correlations with BC were less relevant, with the LM explaining 6.7% of BMD at LS; 15.2% of FN, 16% of FT, whereas the FM explained 8.1% of LS; 179% of FN and 176% of FT. Conclusion: LM in untreated women was better predictor of BMD than FM, especialy for distal femur, where it explained more than 30% of the BMD, suggesting that maintaining a healthy muscle mass may contribute to decrease osteoporosis risk. Treatment with anti-osteoporotic drugs seems to mask these relationships. Arch Endocrinol Metab. 2018;62(4):431-7
Subject(s)
Humans , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Thinness/physiopathology , Body Composition/physiology , Bone Density/physiology , Osteoporosis, Postmenopausal/physiopathology , Femur/diagnostic imaging , Body Weight/physiology , Absorptiometry, Photon , Osteoporosis, Postmenopausal/drug therapy , Osteoporosis, Postmenopausal/diagnostic imaging , Adipose Tissue/physiology , Cross-Sectional Studies , Risk Factors , Lumbar Vertebrae/physiology , Lumbar Vertebrae/diagnostic imagingABSTRACT
ABSTRACT Objective Thyrotoxicosis is established risk factor for osteoporosis due to increased bone turnover. Glucocorticoids often administered for Graves' orbitopathy (GO) have additional negative effect on bone mineral density (BMD). Our aim was to examine the influence of thyroid hormones, TSH, TSH-receptor antibodies (TRAb) and glucocorticoid treatment on bone in women with Graves' thyrotoxicosis and Graves' orbitopathy (GO). Subjects and methods Forty seven women with Graves' disease, mean age 55.6 ± 12.8 (23 women with thyrotoxicosis and 24 hyperthyroid with concomitant GO and glucocorticoid therapy) and 40 age-matched healthy female controls were enrolled in the study. We analyzed clinical features, TSH, FT4, FT3, TRAb, TPO antibodies. BMD of lumbar spine and hip was measured by DEXA and 10-year fracture risk was calculated with FRAX tool. Results The study showed significantly lower spine and femoral BMD (g/cm2) in patients with and without GO compared to controls, as well as significantly higher fracture risk. Comparison between hyperthyroid patients without and with orbitopathy found out significantly lower spine BMD in the first group (p = 0.0049). Negative correlations between FT3 and femoral neck BMD (p = 0.0001), between FT4 and BMD (p = 0.049) and positive between TSH and BMD (p = 0.0001), TRAb and BMD (p = 0.026) were observed. Fracture risk for major fractures and TRAb were negatively associated (p = 0.05). We found negative correlation of BMD to duration of thyrotoxicosis and cumulative steroid dose. Conclusions Our results confirm the negative effect of hyperthyroid status on BMD. TRAb, often in high titers in patients with GO, may have protective role for the bone, but further research is needed.
Subject(s)
Humans , Female , Adult , Middle Aged , Aged , Thyroid Hormones/physiology , Osteoporosis, Postmenopausal/physiopathology , Graves Disease/complications , Immunoglobulins, Thyroid-Stimulating/physiology , Graves Ophthalmopathy/complications , Glucocorticoids/adverse effects , Reference Values , Thyrotropin/physiology , Absorptiometry, Photon , Bone Density/drug effects , Bone Density/physiology , Case-Control Studies , Graves Disease/physiopathology , Graves Disease/drug therapy , Fractures, Bone/etiology , Fractures, Bone/physiopathologyABSTRACT
Abstract Background: Coronary artery disease (CAD) and osteoporosis (OP) are common diseases in postmenopausal women. In both cross-sectional and longitudinal epidemiologic studies, low bone mass has been related to increased frequency of CAD. However, available data on the relationship between bone mineral density (BMD) and severity of coronary lesions is limited. Objective: To investigate association between the BMD and severity of coronary lesions assessed by Gensini score in postmenopausal women. Methods: This study included 122 postmenopausal women who were diagnosed with CAD. These patients were divided into two groups according to the severity of coronary lesions assessed by the Gensini score - patients with mild coronary lesions (Gensini score < 25) and patients with severe coronary lesions (Gensini score ≥ 25). Femoral neck mineral density was measured with dual energy X-ray absorptiometry (DXA). Results: The study included postmenopausal women aged 64.31 ± 4.71 years, 85 of whom (69.7%) exhibited severe coronary lesions. Participants with severe coronary lesions had a significantly higher T score than did those with mild coronary lesions at the femoral neck (p < 0.05). The mean T-score was −0.84 ± 1.01 in mild coronary lesions group, −1.42 ± 1.39 in severe coronary lesions group (p < 0.05). Multivariable logistic regression analysis showed that osteopenia-osteoporosis at the Femoral neck (odds ratio 2.73; 95% confidence interval 1.06 to 6.13) was associated with an increased risk of developing severe coronary lesions. The multiple regression model showed that T-scores (b = −0.407, SE = 0.151, p=0.007) were the independent predictors of Gensini score. Conclusion: The relationship between severity of coronary lesions and BMD was significant in postmenopausal women. BMD, a low-cost technique involving minimal radiation exposure, widely used for osteoporosis screening, is a promising marker of severity of coronary lesions.
Resumo Fundamento: A doença arterial coronariana (DAC) e a osteoporose são doenças comuns em mulheres pós-menopausa. Tanto em estudos transversais como em estudos epidemiológicos longitudinais, a massa óssea diminuída foi relacionada à frequência aumentada de DAC. No entanto, dados disponíveis sobre a relação entre densidade mineral óssea (DMO) e gravidade das lesões coronarianas são limitados. Objetivo: Investigar a associação entre DMO e gravidade das lesões coronarianas avaliadas pelo escore de Gensini em mulheres pós-menopausa. Métodos: Este estudo incluiu 122 mulheres pós-menopausa diagnosticadas com DAC. As pacientes foram divididas em dois grupos de acordo com a gravidade das lesões coronarianas avaliada pelo escore de Gensini - pacientes com lesões coronarianas leves (escore de Gensini < 25) e pacientes com lesões coronarianas graves (escore de Gensini ≥ 25). A densidade mineral do colo femoral foi medida por absorção de raios-X de dupla energia (DXA). Resultados: O estudo incluiu mulheres pós-menopausa com idade de 64,31 ± 4,71 anos, 85 delas (69,7%) com lesões coronarianas graves. Pacientes com lesões coronarianas graves apresentaram um escore T mais elevado que aquelas com lesões coronarianas leves no colo femoral (p < 0,05). O escore T médio foi -0,84 ± 1,01 no grupo com lesões leves, e -1,42 ± 1,39 no grupo com lesões graves (p < 0,05). A análise de regressão logística multivariada mostrou que a osteopenia-osteoporose no colo femoral (odds ratio 2,73; intervalo de confiança de 95% 1,06 - 6,13) esteve associada com um risco aumentado de se desenvolver lesões coronarianas graves. O modelo de regressão múltipla mostrou que os escores T (b = -0,407; EP= 0,151; p = 0,007) foram preditores independentes do escore de Gensini. Conclusão: Encontrou-se uma relação significativa entre a gravidade das lesões coronarianas e a DMO em mulheres pós-menopausa. DMO, uma técnica de baixo custo que envolve mínima exposição à radiação, e amplamente utilizada no rastreamento de osteoporose, é um marcador promissor da gravidade de lesões coronarianas graves.
Subject(s)
Humans , Female , Middle Aged , Aged , Coronary Artery Disease/physiopathology , Bone Density/physiology , Osteoporosis, Postmenopausal/physiopathology , Postmenopause/physiology , Bone Demineralization, Pathologic/physiopathology , Reference Values , Severity of Illness Index , Coronary Artery Disease/etiology , Absorptiometry, Photon/methods , Logistic Models , Osteoporosis, Postmenopausal/complications , Cross-Sectional Studies , Risk Factors , Age Factors , Statistics, Nonparametric , Risk Assessment , Bone Demineralization, Pathologic/complications , Femur Neck/diagnostic imaging , Hyperlipidemias/complicationsABSTRACT
Abstract Osteoporosis is an insidious and increasingly prevalent disease that can cause fractures and affect patients' quality of life. The current study comparatively evaluates patients with and without loss of bone mass in terms of salivary calcium, viscosity, and pH. A controlled cross-sectional study was conducted in two groups of 32 postmenopausal women subjected to a bone densitometry scan and later referred for dental management at the Federal University of Minas Gerais, Brazil. The patients were assigned to two groups: Group 1 - patients with low bone mineral density (BMD) and Group 2 - patients without bone mineral changes. The following salivary parameters were evaluated: calcium concentration, flow rate, viscosity, pH, and average total protein. An oral examination was performed for assessment of DMFT variables and tongue coating. Data were analyzed using descriptive and inferential statistics, adopting a p-value < 0.05. The patients' mean age was 60 years (± 7.35). Salivary flow, pH, and viscosity were similar among the groups. Average total protein was 14.8 mg/mL and 19.0 mg/mL in Groups 1 and 2, respectively. Tongue coating and salivary calcium levels were significantly higher in Group 1 (p < 0.001). Salivary calcium is an important screening tool and may eventually be used for the diagnosis of bone mineral changes.
Subject(s)
Humans , Female , Aged , Saliva/chemistry , Osteoporosis, Postmenopausal/physiopathology , Osteoporosis, Postmenopausal/metabolism , Calcium/analysis , Oral Health , Reference Values , Tongue/physiopathology , Viscosity , Proteins/analysis , Absorptiometry, Photon , Bone Density/physiology , Case-Control Studies , DMF Index , Cross-Sectional Studies , Statistics, Nonparametric , Hydrogen-Ion Concentration , Middle AgedABSTRACT
OBJECTIVES: In post-menopausal women with osteoporosis, insufficient vitamin D levels decrease calcium fixation in the bones and calcium transport in the sarcoplasmic reticulum, which impairs muscle strength, possibly leading to detrimental consequences for the preservation of functional capacity and postural balance, fall prevention, and fracture risk. The aim of this study was to evaluate the association between vitamin D levels and knee muscle strength, postural balance and functional mobility among postmenopausal women with osteoporosis. METHODS: This cross-sectional study included 63 osteoporotic older women (aged 60.6±3.1 years). The subjects completed the Timed Up and Go Test to measure functional mobility, and postural balance was assessed on the AccuSway Plus portable force platform. Maximal strength was tested using an isokinetic dynamometer for knee flexion and extension. The subjects were assessed as a group and were divided into quartiles according to their vitamin D levels. Clinicaltrials.gov: NCT02771834. RESULTS: Vitamin D status was independently associated with the normalized peak torque of the knee extensors (β=0.59; p=0.04) and Timed Up and Go Test (β=-0.07; p<0.001). No between-group differences were observed in the demographic and clinical variables or postural balance; however, significant differences were observed in the Timed Up and Go Test, and the group with the highest vitamin D levels exhibited better performance than the group with the lowest vitamin D levels (p<0.001). CONCLUSION: The serum vitamin D levels were independently associated with normalized knee extension strength and functional mobility in postmenopausal women with osteoporosis.
Subject(s)
Humans , Female , Middle Aged , Aged , Vitamin D/analogs & derivatives , Osteoporosis, Postmenopausal/blood , Postural Balance/physiology , Muscle Strength/physiology , Knee Joint/physiology , Vitamin D/blood , Osteoporosis, Postmenopausal/physiopathology , Cross-Sectional StudiesABSTRACT
La osteoporosis es una enfermedad sistémica del esqueleto, con amplia prevalencia sobre todo en mujeres postmenopáusicas. La ortopantomografía (OPMG) es una técnica radiológica de uso generalizado en las consultas de los odontólogos. En el presente estudio se hace una revisión de trabajos en los que, utilizando una serie de índices como: Mandibular Cortical Index (MCI), Mental Index (MI), Panoramic Mandibular Index (PMI), Antegonial Index (AI), Gonial Index (GI), medidos sobre OMPG se plantea la hipótesis de poder detectar precozmente la osteoporosis por este medio. Los resultados expuestos en los diferentes estudios avalan esta hipótesis y así se podrá remitir a los pacientes al especialista para que se les haga un estudio más exhaustivo sobre dicha patología (AU)
Osteoporosis is a systemic skeletal disease, with widespread prevalence especially in postmenopausal women. Orthopantomography (OPMG) is a widely used diagnosis technique in dental practice. The objective of this study is to make a systematic review of studies in which, using a series of indices as Mandibular Cortical Index (MCI), Mental Index (MI), Panoramic Mandibular Index (PMI), Antegonial Index (AI), Gonial Index (GI) measured on panoramic radiographs are useful for detecting early osteoporosis. The results reported in different studies support the possibility that OPMG could be an effective tool to detect early Osteoporosis and refer patients to a specialist to treat their disease (AU)
Subject(s)
Humans , Menopause/physiology , Osteoporosis, Postmenopausal/physiopathology , Absorptiometry, Photon/methods , Osteoporosis , Early Diagnosis , Radiography, Panoramic/methodsSubject(s)
Humans , Female , Middle Aged , Osteoporosis, Postmenopausal/diagnosis , Osteoporosis, Postmenopausal/drug therapy , Diphosphonates/therapeutic use , Strontium/therapeutic use , Alendronate/therapeutic use , Osteoporosis, Postmenopausal/prevention & control , Osteoporosis, Postmenopausal/physiopathology , Primary Prevention/methods , Primary Prevention/trends , Cross-Sectional Studies/methods , Densitometry , Menopause , Menopause/metabolism , 28599ABSTRACT
OBJECTIVE: The aims of this study were to evaluate the anteroposterior displacement behavior of the center of pressure without any visual reference and determine its relationship with knee muscle strength and reports of falls in postmenopausal women. Among those with osteoporosis, the specific objective was to evaluate the correlation of thoracic kyphosis and vitamin D with center of pressure displacement. METHODS: This was a cross-sectional observational study without intervention. The assessments were performed on 126 postmenopausal women (aged 55-65 years) who were grouped according to their lumbar bone density into osteoporosis and control groups. Center of pressure was evaluated on a force platform (100 Hz frequency and 10 Hz filter), with the subjects standing on both feet with eyes closed for 60 seconds. Knee muscle strength was evaluated using an isokinetic dynamometer in concentric/concentric mode at a velocity of 60°/s. In the osteoporosis group, vitamin D was assayed, and the thoracic spine was radiographed. RESULTS: In the control group, there was a correlation between the center of pressure and knee strength (r = 0.37; p<0.003). Reports of falls were not associated with center of pressure displacement (p = 0.056). In the osteoporosis group, thoracic kyphosis and vitamin D levels were not correlated with the center of pressure. CONCLUSION: Anteroposterior center of pressure displacement without visual influence was not associated with falls, thoracic kyphosis or vitamin D in the osteoporosis group. Only knee muscle strength was associated with center of pressure displacement in the control group. .